Schonfeld Strategic Advisors’s Science Strategic Acquisition Corp. Alpha Class A Common Stock SSAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-35,100
Closed -$346K 3307
2022
Q3
$346K Buy
35,100
+14,495
+70% +$143K ﹤0.01% 1999
2022
Q2
$202K Buy
20,605
+2,300
+13% +$22.5K ﹤0.01% 1882
2022
Q1
$180K Buy
18,305
+1,167
+7% +$11.4K ﹤0.01% 2026
2021
Q4
$167K Buy
17,138
+1,155
+7% +$11.3K ﹤0.01% 1785
2021
Q3
$155K Buy
15,983
+5,983
+60% +$58.1K ﹤0.01% 1838
2021
Q2
$97K Buy
+10,000
New +$97.8K ﹤0.01% 1834

Schonfeld Strategic Advisors's SSAA Position: Q4 2022 in Review

Schonfeld Strategic Advisors sold out of Science Strategic Acquisition Corp. Alpha Class A Common Stock (SSAA) in Q4 2022, closing a stake of 35,100 shares — an estimated $346K sold.

Schonfeld Strategic Advisors first reported a position in SSAA in Q2 2021 and held it in 6 quarters. The position peaked at $346K in Q3 2022. 0 funds tracked by Wall St. Rank hold SSAA as of Q4 2022.

  • Schonfeld Strategic Advisors reported no remaining Science Strategic Acquisition Corp. Alpha Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 35,100 Science Strategic Acquisition Corp. Alpha Class A Common Stock shares in Q4 2022, an estimated $346K.
  • Schonfeld Strategic Advisors first reported a position in Science Strategic Acquisition Corp. Alpha Class A Common Stock in Q2 2021 and held it in 6 quarters.
  • Schonfeld Strategic Advisors's Science Strategic Acquisition Corp. Alpha Class A Common Stock position peaked at $346K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Science Strategic Acquisition Corp. Alpha Class A Common Stock as of Q4 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.